세계의 신경독 모방 펩티드 시장 보고서(2025년)
Neurotoxin-Inspired Peptide Global Market Report 2025
상품코드 : 1855933
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,666,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,635,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,605,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

신경독 모방 펩티드 시장 규모는 최근 급속도로 확대되고 있습니다. 2024년 10억 8,000만 달러에서 2025년에는 12억 2,000만 달러에 달하고, CAGR 13.9%로 확대될 전망입니다. 과거 조사기간 내 성장의 원동력은 신경약리학 연구에 대한 투자 증가, 천연 유래의 치료제에 대한 주목 증가, 학술기관과 산업기관의 협력 관계의 확대, 신규 치료에 대한 수요를 자극하는 신경질환의 유병률의 상승, 해양 및 육상 독소 연구에 대한 관심 증가입니다.

신경독 모방 펩티드 시장 규모는 향후 수년간 급성장할 것으로 전망됩니다. 2029년에는 CAGR 13.6%로 20억 4,000만 달러로 성장할 전망입니다. 예측 기간 동안의 성장은 표적 신경치료제에 대한 수요 증가, 펩티드 탐색에서의 인공지능 통합의 발전, 정밀의료 전략의 중요성 증가, 바이오 의약품 제조 인프라 투자 증가, 비침습적 전달 시스템의 광범위한 채택에 의해 지원될 것으로 예측됩니다. 예측 기간 동안 예상되는 주요 동향으로는 고처리량 펩티드 스크리닝 플랫폼의 발전, 펩티드 수용체 상호작용 분석을 위한 계산 모델링의 이용 확대, 차세대 펩티드 안정화 기술의 개발, 나노포뮬레이션에 의한 펩티드 전달 시스템의 개선, 구조활성 최적화를 위한 머신러닝 알고리즘의 통합 등이 있습니다.

신경질환의 유병률 증가는 향후 수년간 신경독 모방 펩티드 시장의 성장을 가속화할 것으로 예측됩니다. 신경질환은 뇌, 척수, 뇌신경, 말초신경 등 중추신경계 및 말초신경계에 영향을 미치는 광범위한 질환을 포함하며, 운동기능, 감각기능, 인지기능, 자율신경기능에 영향을 미칩니다. 이러한 증상 증가의 배경에는 세계적인 평균 수명의 연장이 중요한 요인이 되고 있습니다. 수명이 연장됨으로써 신경계의 노화와 관련된 퇴행성 변화의 위험이 높아져 이러한 증상의 발생률이 높아지기 때문입니다. 신경독 모방 펩티드는 특정 신경경로를 정확하게 표적으로 함으로써 혁신적인 치료 접근법을 제공하고, 치료 결과를 개선할 수 있으며, 신경질환의 부담 증가에 따른 의료 수요에 대응합니다. 예를 들어, 2023년 10월 영국을 거점으로 하는 각국의 신경학회의 연합체인 세계신경과연맹(World Federation of Neurology)은 뇌질환을 앓고 있는 세계 인구가 2050년까지 두배로 늘고 뇌졸중 관련 사망률은 50% 증가하여 2050년까지 연간 970만명에 달할 것으로 예측했습니다. 따라서 신경질환의 유병률 증가는 신경독 모방 펩티드 시장의 활성화로 이어질 것으로 예측됩니다.

신경독 모방 펩티드 시장의 주요 기업은 주사 치료에 필적하는 주름 개선 효과를 가진 비침습적 스킨케어 솔루션을 제공하는 펩티드 미용액 등의 혁신적인 제품의 개발에 주력하고 있습니다. 신경독 모방 펩티드 미용액은 생체 모방 펩티드와 보완적인 활성제를 사용한 국소 제제로 침습적인 처치를 하지 않고 얼굴의 근육과 관련된 표정 주름을 줄이고 피부의 질감과 광택을 높입니다. 예를 들어, 2024년 7월 미국의 의료용 스킨케어 브랜드인 SkinCeuticals사는 P-TIOX를 출시했습니다. P-TIOX는 첨단 펩티드 복합체와 박리제 및 보습제를 결합한 특허출원 중인 처방으로 눈에 보이는 피부를 매끄럽게 하고, 모공을 수축시키고, 여러 유형의 표정 주름을 개선하도록 설계되어 있습니다. 단독 사용과 주사에 의한 신경독 시술의 보완 모두에서 임상 평가되고 있으며, 안티에이징 스킨 케어에서 비침습적인 중요한 진보를 상징합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

CSM
영문 목차

영문목차

Neurotoxin-inspired peptides are engineered peptides modeled on natural neurotoxins, developed for therapeutic, cosmetic, and biomedical applications. They harness the precision and potency of neurotoxins to create targeted treatments, drug delivery systems, and innovative biopharmaceutical solutions.

The primary product categories of neurotoxin-inspired peptides include synthetic peptides, recombinant peptides, natural peptides, and others. Synthetic peptides are artificially designed amino acid chains that replicate the structure or function of natural neurotoxins to influence nerve signaling for therapeutic or research purposes. These products are distributed through channels such as direct sales, online platforms, and distributors, and are applied in pharmaceuticals, cosmetics, and research and development. End users include hospitals and clinics, research institutions, biotechnology companies, and related organizations.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The neurotoxin-inspired peptide market research report is one of a series of new reports from The Business Research Company that provides neurotoxin-inspired peptide market statistics, including neurotoxin-inspired peptide industry global market size, regional shares, competitors with a neurotoxin-inspired peptide market share, detailed neurotoxin-inspired peptide market segments, market trends and opportunities, and any further data you may need to thrive in the neurotoxin-inspired peptide industry. This neurotoxin-inspired peptide market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The neurotoxin-inspired peptide market size has grown rapidly in recent years. It will grow from $1.08 billion in 2024 to $1.22 billion in 2025 at a compound annual growth rate (CAGR) of 13.9%. The growth during the historic period was driven by increased investment in neuropharmacology research, heightened focus on naturally derived therapeutic agents, expanding collaborations between academic and industrial organizations, rising prevalence of neurological disorders fueling demand for novel treatments, and growing interest in marine and terrestrial toxin research.

The neurotoxin-inspired peptide market size is expected to see rapid growth in the next few years. It will grow to $2.04 billion in 2029 at a compound annual growth rate (CAGR) of 13.6%. The growth during the forecast period is expected to be supported by rising demand for targeted neurological therapeutics, greater integration of artificial intelligence in peptide discovery, increasing emphasis on precision medicine strategies, higher investments in biopharmaceutical manufacturing infrastructure, and wider adoption of non-invasive delivery systems. Key trends anticipated in the forecast period include the advancement of high-throughput peptide screening platforms, expanded use of computational modeling for peptide-receptor interaction analysis, development of next-generation peptide stabilization techniques, improvement of peptide delivery systems with nanoformulations, and integration of machine learning algorithms for structure-activity optimization.

The increasing prevalence of neurological disorders is expected to drive the growth of the neurotoxin-inspired peptide market in the coming years. Neurological disorders encompass a wide range of conditions affecting the central and peripheral nervous systems, including the brain, spinal cord, cranial nerves, and peripheral nerves-impacting motor, sensory, cognitive, and autonomic functions. A key factor behind this rise is the global increase in life expectancy, as longer lifespans elevate the risk of age-related degenerative changes in the nervous system, thereby increasing the incidence of these conditions. Neurotoxin-inspired peptides offer innovative therapeutic approaches by precisely targeting specific neurological pathways, potentially improving treatment outcomes and addressing unmet medical needs associated with the growing burden of neurological disorders. For example, in October 2023, the World Federation of Neurology, a UK-based association of national neurological societies, projected that the global population living with brain diseases will double by 2050, while stroke-related deaths are expected to rise by 50% to reach 9.7 million annually by that year. Therefore, the rising prevalence of neurological disorders is anticipated to fuel the neurotoxin-inspired peptide market.

Leading companies in the neurotoxin-inspired peptide market are focusing on developing innovative products such as peptide serums that provide non-invasive skincare solutions with wrinkle-reducing effects comparable to injectable treatments. A neurotoxin-inspired peptide serum is a topical formulation using biomimetic peptides and complementary actives to reduce facial muscle-related expression lines and enhance skin texture and radiance without invasive procedures. For instance, in July 2024, SkinCeuticals, a US-based medical skincare brand, launched P-TIOX-a serum combining an advanced peptide complex with exfoliating and hydrating agents in a patent-pending formula designed to visibly smooth skin, refine pores, and reduce multiple types of contraction lines. Clinically evaluated for both standalone use and as a complement to injectable neurotoxin procedures, it represents a significant non-invasive advancement in anti-aging skincare.

In February 2025, Crown Laboratories, Inc., a US-based skincare company, acquired Revance Therapeutics, Inc. for approximately $924 million. This acquisition aims to combine Crown's global aesthetic and skincare expertise with Revance's peptide-based neuromodulator technologies, enhancing product innovation, expanding market reach, and solidifying leadership in neurotoxin and peptide aesthetic therapeutics. Revance Therapeutics is a US-based biotechnology company specializing in peptide-formulated neuromodulators.

Major players in the neurotoxin-inspired peptide market are AbbVie Inc., Galderma, Ipsen Pharma, Biolab Farmaceutica, Daewoong Pharmaceutical, Luye Pharma Group, CordenPharma, Syngene International, Shanghai Haohai Bio., Hugel Inc., Merz Pharma, Evolus Inc., Medytox Inc., US WorldMeds, Smartox Biotechnology, Venomtech Ltd., Latoxan, Pepscan Therapeutics, ToxinTech Inc., AEON Biopharma Inc.

North America was the largest region in the neurotoxin-inspired peptide market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in neurotoxin-inspired peptide report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the neurotoxin-inspired peptide market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The neurotoxin-inspired peptide market consists of sales of products such as botulinum toxin formulations, dermal fillers with peptide enhancers, anti-wrinkle injectables, peptide-based neuromodulator creams, and cosmetic serums with peptide complexes. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Neurotoxin-Inspired Peptide Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on neurotoxin-inspired peptide market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for neurotoxin-inspired peptide ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The neurotoxin-inspired peptide market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Neurotoxin-Inspired Peptide Market Characteristics

3. Neurotoxin-Inspired Peptide Market Trends And Strategies

4. Neurotoxin-Inspired Peptide Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Neurotoxin-Inspired Peptide Growth Analysis And Strategic Analysis Framework

6. Neurotoxin-Inspired Peptide Market Segmentation

7. Neurotoxin-Inspired Peptide Market Regional And Country Analysis

8. Asia-Pacific Neurotoxin-Inspired Peptide Market

9. China Neurotoxin-Inspired Peptide Market

10. India Neurotoxin-Inspired Peptide Market

11. Japan Neurotoxin-Inspired Peptide Market

12. Australia Neurotoxin-Inspired Peptide Market

13. Indonesia Neurotoxin-Inspired Peptide Market

14. South Korea Neurotoxin-Inspired Peptide Market

15. Western Europe Neurotoxin-Inspired Peptide Market

16. UK Neurotoxin-Inspired Peptide Market

17. Germany Neurotoxin-Inspired Peptide Market

18. France Neurotoxin-Inspired Peptide Market

19. Italy Neurotoxin-Inspired Peptide Market

20. Spain Neurotoxin-Inspired Peptide Market

21. Eastern Europe Neurotoxin-Inspired Peptide Market

22. Russia Neurotoxin-Inspired Peptide Market

23. North America Neurotoxin-Inspired Peptide Market

24. USA Neurotoxin-Inspired Peptide Market

25. Canada Neurotoxin-Inspired Peptide Market

26. South America Neurotoxin-Inspired Peptide Market

27. Brazil Neurotoxin-Inspired Peptide Market

28. Middle East Neurotoxin-Inspired Peptide Market

29. Africa Neurotoxin-Inspired Peptide Market

30. Neurotoxin-Inspired Peptide Market Competitive Landscape And Company Profiles

31. Neurotoxin-Inspired Peptide Market Other Major And Innovative Companies

32. Global Neurotoxin-Inspired Peptide Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Neurotoxin-Inspired Peptide Market

34. Recent Developments In The Neurotoxin-Inspired Peptide Market

35. Neurotoxin-Inspired Peptide Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기